Collateral for a security interest recorded Mar 16, 2026 (Symbiotic Capital Agency LLC).
Lapsed Dec 27, 2023 on the fee record · High confidence
20-year base term ended Aug 18, 2025
Third maintenance fee unpaid; grace period ended.
Held by Vero Biotech Inc.
Filed Jul 10, 2009 as application 12/500,929 · Granted Dec 27, 2011
Base term plus 308 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Lapsed Dec 27, 2023
2005
2026
Clock starts
Aug 18, 2005
Aug 18, 2005
Term ended
Dec 27, 2023
Dec 27, 2023
Granted
Dec 27, 2011
Dec 27, 2011
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
308
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,560,076, US 7,618,594, US 7,914,743.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
19
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Sep 7, 2023: its 20-year base term plus 308 days of term adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 18, 2005, when application 11/206,305, the earliest non-provisional in its chain, was filed (this one was filed Jul 10, 2009) | Aug 18, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +308 days, USPTO patent term adjustment record | Jun 22, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,560,076, US 7,618,594, US 7,914,743) | capped to Sep 7, 2023 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | lapsed Dec 27, 2023 | High confidence |
| Computed term end | The steps above, in order | Dec 27, 2023 | High confidence |
This family
| Application 60/602,333 | Provisional application no patent term | no patent term |
| Application 60/659,094 | Provisional application no patent term | no patent term |
| US 7,560,076 | In force Apr 2027 | Apr 2027 |
| US 7,618,594 | Term ended Sep 2023 | Sep 2023 |
| US 8,083,997 | this patent Dec 2023 | Dec 2023 |
| US 8,057,742 | Term ended Sep 2023 | Sep 2023 |
| US 8,246,725 | Term ended Aug 2025 | Aug 2025 |
| US 8,226,916 | Term ended Sep 2023 | Sep 2023 |
8 of 19 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 15, 2011 Reel 27227, frame 610 | Rounbehler, David P.; Fine, David H. | Geno LLC | Assignment of Assignor's Interest |
| Jun 6, 2018 Reel 46304, frame 855 | Geno LLC | Vero Biotech LLC | Change of Name |
| Dec 29, 2020 Reel 54866, frame 589 | Vero Biotech LLC | Runway Growth Credit Fund Inc. | Security Interest |
| Sep 1, 2021 Reel 57360, frame 91 | Rounbehler, David P.; Fine, David H. | Cyterra Corporation | Assignment of Assignor's Interest |
| Sep 1, 2021 Reel 57360, frame 96 | Cyterra Corporation | Geno LLC | Assignment of Assignor's Interest |
| Feb 14, 2022 Reel 59085, frame 418 | Vero Biotech LLC | Vero Biotech Inc. | Change of Name |
| Jan 3, 2024 Reel 66186, frame 611 | Runway Growth Finance Corp. (F/K/A Runway Growth Credit Fund Inc.) | Vero Biotech Inc. (F/K/A Vero Biotech LLC) | Termination and Release of Intellectual Property Security Agreement |
| Jan 3, 2024 Reel 66187, frame 865 | Vero Biotech Inc. | Horizon Technology Finance Corporation | Security Interest |
| Mar 16, 2026 Reel 75117, frame 935 | Vero Biotech Inc. | Symbiotic Capital Agency LLC, as Collateral Agent | Security Interest |
| Mar 18, 2026 Reel 75308, frame 198 | Horizon Technology Finance Corporation | Vero Biotech Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 308 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 7,560,076, US 7,618,594, US 7,914,743.
Citations
40
later US patents cite this one
That is top 25% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.